Table A3.
Number and percent of overall cohort outside of normal clinical range for eGFR, SUA, BUN, and ACR, along with the distribution of subjects within the overall cohort across clinical categories.
| N (% of overall cohort) | ||
| eGFR clinical cutoffs |
normal ≥ 75 mL/min/1.73m2 |
2684 (100%) |
|
abnormal < 75 mL/min/1.73m2 |
1 (0%) | |
|
chronic kidney disease ≤ 60 mL/min/1.73m2 |
4 (0%) | |
| SUA clinical cutoffs |
normal 12–18yo: 3.5–7.3 mg/dL 19yo: male: 3.6–8.4 mg/dL 19yo: female: 2.9–7.5 mg/dL |
2481 (92%) |
|
below normal range 12–18yo: < 3.5 mg/dL 19yo: male: < 3.6 mg/dL 19yo: female: < 2.9 mg/dL |
99 (4%) | |
|
above normal range 12–18yo: > 7.3 mg/dL 19yo: male: > 8.4 mg/dL 19yo: female: > 7.5 mg/dL |
109 (4%) | |
| BUN clinical cutoffs |
normal 12–15yo: 7–18 mg/dL 15–19yo: 6–23 mg/dL |
2484 (92%) |
|
below normal range 12–15yo: < 7 mg/dL 15–19yo: < 6 mg/dL |
190 (7%) | |
|
above normal range 12–15yo: > 18 mg/dL 15–19yo: > 23 mg/dL |
15 (1%) | |
| ACR clinical cutoffs |
normal < 20 mg/g |
2175 (81%) |
|
mild 20–30 mg/g |
165 (6%) | |
|
moderate 30–300 mg/g |
315 (12%) | |
|
severe >300 mg/g |
36 (1%) | |